TrialMedical science monitor basic research2017

Cross-Over Study Comparing Postprandial Glycemic Increase After Addition of a Fixed-Dose Mitiglinide/Voglibose Combination or a Dipeptidyl Peptidase-4 Inhibitor to Basal Insulin Therapy in Patients with Type 2 Diabetes Mellitus.

Noriko Ihana-Sugiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.